Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
8.23
-0.15 (-1.79%)
At close: Apr 1, 2025, 4:00 PM
8.41
+0.18 (2.25%)
Pre-market: Apr 2, 2025, 4:14 AM EDT

Amneal Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
2,5512,4541,861301715675
Upgrade
Market Cap Growth
31.88%31.88%517.29%-57.87%6.05%4.38%
Upgrade
Enterprise Value
5,0325,0814,4342,9893,3723,471
Upgrade
Last Close Price
8.237.926.071.994.794.57
Upgrade
PE Ratio
----67.357.41
Upgrade
Forward PE
12.1011.6911.922.715.657.07
Upgrade
PS Ratio
0.910.880.780.140.340.34
Upgrade
PB Ratio
-57.28-55.1030.351.441.861.89
Upgrade
P/FCF Ratio
10.8710.456.2318.493.752.13
Upgrade
P/OCF Ratio
8.648.325.384.632.961.78
Upgrade
PEG Ratio
0.510.510.510.180.662.65
Upgrade
EV/Sales Ratio
1.801.821.851.351.611.74
Upgrade
EV/EBITDA Ratio
8.618.698.856.797.499.11
Upgrade
EV/EBIT Ratio
14.4414.5916.3414.9415.5723.83
Upgrade
EV/FCF Ratio
21.4321.6414.84183.2917.6710.94
Upgrade
Debt / Equity Ratio
-58.22-58.2244.8713.627.528.41
Upgrade
Debt / EBITDA Ratio
4.284.285.266.156.157.36
Upgrade
Debt / FCF Ratio
11.0511.059.21174.5015.139.46
Upgrade
Asset Turnover
0.800.800.660.570.530.52
Upgrade
Inventory Turnover
2.982.982.752.792.673.08
Upgrade
Quick Ratio
0.820.820.871.101.391.49
Upgrade
Current Ratio
1.411.411.631.882.252.29
Upgrade
Return on Equity (ROE)
-881.26%-881.26%-36.06%-85.96%5.45%19.50%
Upgrade
Return on Assets (ROA)
6.24%6.24%4.67%3.23%3.41%2.37%
Upgrade
Return on Capital (ROIC)
8.12%8.12%5.78%3.95%4.08%2.81%
Upgrade
Return on Capital Employed (ROCE)
14.70%14.70%10.30%6.60%6.60%4.40%
Upgrade
Earnings Yield
-4.58%-4.76%-4.51%-43.12%1.49%13.50%
Upgrade
FCF Yield
9.20%9.57%16.06%5.41%26.68%47.01%
Upgrade
Buyback Yield / Dilution
-75.42%-75.42%-16.69%0.58%-1.95%-12.72%
Upgrade
Total Shareholder Return
-75.42%-75.42%-16.69%0.58%-1.95%-12.72%
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q